IRDAI fines Axis Bank Rs 2 crore, Max Life Rs 3 crore over share deals

What the Record Shows

The Insurance Regulatory and Development Authority of India (IRDAI) imposed a penalty of Rs 2 crore on Axis Bank Ltd through an order dated 13 October 2022, bearing reference IRDA/F&A/ORD/FA/215/10/2022 and signed by the Authority's Chairman. In a parallel order in the same matter, the Authority imposed a penalty of Rs 3 crore on Max Life Insurance Company Ltd. Both orders arose from a set of share transactions in the insurer's equity between Axis Bank and its group companies on one side and the insurer's promoters on the other.

Per the Axis Bank order, the Rs 2 crore was made up of two separate penalties of Rs 1 crore each, imposed under Section 102(b) of the Insurance Act, 1938, and payable within 21 days of the order. Axis Bank holds a corporate agent's certificate of registration (CA00069) to solicit insurance for Max Life, and the Authority examined its conduct in that capacity. The order records that the transactions passed undue monetary gain to the corporate agent in a way the Authority found circumvented the limits on commission and remuneration.

This is a bancassurance-governance matter, not a consumer mis-selling case. It concerns the integrity of the approval regime for changes in an insurer's shareholding and the caps on what a bank acting as an insurance agent may earn, rather than the sale of any policy to a customer. Max Life said it would pay the penalty while maintaining that it had not committed any violation. Both orders are appealable to the Securities Appellate Tribunal under Section 110 of the Insurance Act, 1938.

How It Worked

The mechanism is set out in the Authority's order. Under Section 6A of the Insurance Act, 1938 read with the IRDAI (Transfer of Equity Shares of Insurance Companies) Regulations, 2015, an insurer must seek the Authority's prior approval for share transfers above defined thresholds. Max Life applied for such approval where Axis Bank, together with Axis Capital Ltd and Axis Securities Ltd, proposed to acquire 12.002 per cent of the insurer's equity held by Max Financial Services Ltd (MFSL).

While processing that application, the Authority found a series of purchase and sale transactions in the insurer's shares between the promoters, MFSL and Mitsui Sumitomo Insurance (MSI), and Axis Bank between 2016 and 2021. Per the order's own table, shares moved between the parties at widely varying prices: Axis Bank had at points sold the insurer's shares to the promoters at prices such as Rs 108, Rs 115, Rs 134 and Rs 166 per share, while in 2021 Axis Bank and its group companies bought large blocks back from MFSL at around Rs 31.51 to Rs 32.12 per share. The order records that there was "no uniform basis for determination of price for transfer of shares".

The Authority had directed, by letters dated 5 February 2016 and 28 January 2021, that the basis for calculating fair market value be clear and uniformly followed across the related agreements. Per the order, Axis Bank did not comply with those directions, and the differential pricing meant the corporate agent received undue monetary gain from the buying and selling of the insurer's equity. The Authority held that this circumvented the limits set under Section 40(2) of the Insurance Act, 1938 read with the commission-payment and corporate-agent regulations.

On the two charges it decided against Axis Bank, the Authority recorded, first, that the bank had not complied with its directions of 5 February 2016 and 28 January 2021, and second, that by undertaking the transactions it had circumvented the maximum limits on commission or remuneration for a corporate agent. It imposed Rs 1 crore for each, Rs 2 crore in total. In the parallel Max Life order, the Authority's charges included violation of its directions and what it described as misrepresentation made to obtain approval for the transfer, for which it imposed Rs 3 crore.

Who Lost Money

This matter does not have a set of defrauded depositors or mis-sold policyholders at its centre, and the orders do not quantify any loss to individual customers. It is important to be precise about that: no consumer loss was established or awarded here. The harm the Authority acted on is to the integrity of two protections that sit upstream of the consumer.

The first is the approval regime for insurer shareholding. The Authority found, per the Max Life order, that approval for the share transfer had been obtained on the basis of a misrepresentation, which strikes at the reliability of the process by which regulators police who owns and controls a life insurer. The second is the cap on what a bancassurance partner may earn. The commission and remuneration limits exist precisely so that a bank steering customers to a particular insurer cannot be over-rewarded in ways that distort that advice. Per the order, the differential share pricing passed undue monetary gain to the corporate agent outside those limits.

So while no rupee figure of customer loss appears, the sums involved in the underlying transactions ran to hundreds of crores, and the penalties address conduct the regime is designed to prevent rather than compensate any named victim.

Where It Stands Now

As of today, the orders of October 2022 stand. The Axis Bank order is published on the IRDAI website as the Order in the matter of M/s Axis Bank Limited, and a review of the Authority's records and appellate listings turned up no order staying or setting aside either penalty.

Max Life publicly stated at the time that it would pay the Rs 3 crore penalty rather than pursue litigation, while maintaining that it believed it had not committed any violation. That decision closes the appeal question for the Max Life order on the current record. For Axis Bank, the order was payable within 21 days and carried the right of appeal to the Securities Appellate Tribunal under Section 110; as reviewed for this report, no appellate order reversing it is on the public record, so the penalty stands.

Because these are regulatory penalties under the insurance statutes and not criminal proceedings, they do not amount to any criminal conviction. The order also directed Axis Bank to place the matter before its board so that preventive steps could be taken.

What It Means

The value of this matter for an ordinary policyholder is in what it reveals about the plumbing behind bancassurance. When you buy a policy through your bank, that bank is a licensed corporate agent, and the regulator caps what it can earn from steering business to a particular insurer. The order is an example of the Authority enforcing those caps even when the reward is dressed up as something other than commission, here as gains on share transactions.

The concrete takeaway is not alarm but awareness. If a bank recommends a specific insurer's policy, that recommendation sits within a regulated commission structure, and you are entitled to compare the product on its merits. You can verify whether an entity is a registered insurer or intermediary on the IRDAI website, and raise a grievance through the Bima Bharosa portal. For the wider run of such actions, the enforcement archive collects regulator orders as they are recorded, including parallel IRDAI penalties on HDFC Life Insurance and Star Health.

FAQ

What exactly did IRDAI order?

IRDAI, by orders dated October 2022, imposed a Rs 2 crore penalty on Axis Bank Ltd and a Rs 3 crore penalty on Max Life Insurance Company Ltd. Per the Axis Bank order, the penalty was for not complying with the Authority's directions and for circumventing the limits on a corporate agent's remuneration through share transactions in the insurer's equity, and was levied under Section 102(b) of the Insurance Act, 1938.

Is this a consumer mis-selling case?

No. It is a bancassurance-governance matter. It concerns the approval regime for changes in an insurer's shareholding and the caps on what a bank acting as a corporate agent may earn, not the sale of any policy to a customer. The orders do not quantify any loss to individual policyholders.

Is this a criminal case?

No. These are administrative orders under the insurance statutes, not criminal convictions. They record breaches the Authority found and impose monetary penalties. Both orders can be appealed to the Securities Appellate Tribunal.

Did the companies appeal?

Max Life said it would pay the Rs 3 crore penalty rather than litigate, while maintaining it believed it had not committed any violation. The Axis Bank order carried a right of appeal to the Securities Appellate Tribunal under Section 110 of the Insurance Act, 1938; as reviewed for this report, no appellate order setting aside either penalty is on the public record, so they stand.

Were policyholders compensated?

No. The penalties are paid to the government and are punitive; the orders do not quantify or award any loss to policyholders. The concern the Authority acted on was the integrity of the shareholding-approval process and the commission caps that protect policyholder interests upstream.

Where can I read the official order?

The Axis Bank order is published on the IRDAI website as the Order in the matter of M/s Axis Bank Limited, bearing reference IRDA/F&A/ORD/FA/215/10/2022. The direct link appears in the source note below.

This report is based on the IRDAI order dated 13 October 2022 in the matter of M/s Axis Bank Limited and the parallel order on Max Life Insurance Company Ltd, together with the companies' public statements, reviewed on 30 July 2026.